SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Advanced Viral Research CP (ADVR)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: maho who wrote (1921)12/28/1996 10:10:00 PM
From: BARRY ALLEN   of 2281
 
I'm not trying to be a wise ass, but the news release told us what's happening in the interim. I don't think ADVR can give us a day to day report all the time although it would be welcome. What I read from this is that soon the second phase results will be in and I'm sure some announcment will be made. What else can they tell us now? It looks like they are focusing on the testing as opposed to sales. You also have to assume that the testing is connected to seeking FDA approval.We are all anxious with our investment but just think how quickly this year passed. Last year at this time ADVR was in the teens and despite all the tax selling it is a solid .30 roughly a 75% increase. That's pretty darn good for the long term holders. It's only up from here and only time will tell how soon and how high!

Tuesday December 10 9:01 AM EDT
<<"In view of the encouraging preliminary results of this clinical study in AIDS patients and the absence of any toxic side effects, we are eager to move forward to the next stage of this clinical trial with RETICULOSE," said Shalom Z.Hirschman, M.D., President and Chief Executive Officer of Advanced Viral Research Corp. "Drs. Fraser, Roach and Levett plan to submit the results for publication upon completion of the trial.">>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News